Clinical Trial Update: Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating an ocular telemetry sensor in patients treated with tafluprost for glaucoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Tafluprost (tafluprost)

Snippet

Sponsor: Sensimed AG | Conditions: Glaucoma | Phase 4 | Status: TERMINATED